Published in Hippokratia on April 01, 2010
First report of a Pseudomonas aeruginosa isolate coharboring KPC and VIM carbapenemases. Antimicrob Agents Chemother (2012) 0.94
Emergence of Klebsiella pneumoniae Coharboring KPC and VIM Carbapenemases in Colombia. Antimicrob Agents Chemother (2012) 0.91
Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade. Eur J Clin Microbiol Infect Dis (2015) 0.90
Characterization of a novel Klebsiella pneumoniae sequence type 476 carrying both bla KPC-2 and bla IMP-4. Eur J Clin Microbiol Infect Dis (2012) 0.82
Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure. Eur J Clin Microbiol Infect Dis (2013) 0.80
Detection of New Delhi Metallo-Beta-Lactamase-1 (NDM-1) in carbapenem- resistant Klebsiella pneumoniae isolated from a university hospital in Iran. Hippokratia (2016) 0.75
A cluster of KPC-2 and VIM-2-producing Klebsiella pneumoniae ST833 isolates from the pediatric service of a Venezuelan Hospital. BMC Infect Dis (2016) 0.75
Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam-β-Lactamase Inhibitor Combinations. J Clin Microbiol (2015) 0.75
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis (2009) 15.19
Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol (2007) 7.30
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother (2007) 2.50
Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory. J Clin Microbiol (2008) 2.18
Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother (2009) 1.97
Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases. Antimicrob Agents Chemother (2009) 1.17
Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol (2000) 2.67
IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob Agents Chemother (2000) 2.62
An integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1. J Antimicrob Chemother (2001) 1.60
Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin. J Hosp Infect (2010) 1.54
Extended-spectrum beta-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals. Int J Antimicrob Agents (2003) 1.46
Extended high-level cross-resistance to antipseudomonal antibiotics amongst Pseudomonas aeruginosa isolates in a university hospital. J Antimicrob Chemother (1997) 1.19
Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis (2004) 1.15
Peritonitis due to Roseomonas fauriae in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol (2000) 1.11
Peritonitis due to Rothia dentocariosa in a patient receiving continuous ambulatory peritoneal dialysis. Clin Infect Dis (1999) 1.04
Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010. Euro Surveill (2012) 1.03
Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa. Hippokratia (2012) 1.02
Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitals. J Antimicrob Chemother (2010) 1.00
Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology. Int J Antimicrob Agents (2007) 0.95
Spread of low-level carbapenem-resistant Acinetobacter baumannii clones in a tertiary care Greek hospital. J Antimicrob Chemother (2003) 0.94
Changes in serum levels of vascular endothelial growth factor in males and females throughout life. J Soc Gynecol Investig (2000) 0.93
Nosocomial spread of an unusual methicillin-resistant Staphylococcus aureus clone that is sensitive to all non-beta-lactam antibiotics, including tobramycin. J Clin Microbiol (2001) 0.92
Antimicrobial resistance and R-factor transfer of salmonellae isolated from chicken carcasses in Greek hospitals. Int J Food Microbiol (1998) 0.91
Gemella morbillorum endocarditis in a child. Pediatr Infect Dis J (2000) 0.91
Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007. J Hosp Infect (2010) 0.89
Predominance of a methicillin-resistant Staphylococcus aureus clone susceptible to erythromycin and several other non-beta-lactam antibiotics in a Greek hospital. J Antimicrob Chemother (2001) 0.88
Inflammatory cytokines in newborn infants. Mediators Inflamm (1998) 0.88
Case of peritonitis caused by Ewingella americana in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol (1999) 0.84
Pseudo-outbreak of imipenem-resistant Acinetobacter baumannii resulting from false susceptibility testing by a rapid automated system. J Clin Microbiol (2000) 0.84
Characterization of Klebsiella pneumoniae clinical strains producing a rare extended-spectrum beta-lactamase (IBC-1). Int J Antimicrob Agents (2003) 0.83
Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece. J Clin Lab Anal (2004) 0.82
Aminoglycoside-resistant staphylococci in Greece: prevalence and resistance mechanisms. Eur J Clin Microbiol Infect Dis (2011) 0.81
Heparin-binding angiogenic factors (basic fibroblast growth factor and vascular endothelial growth factor) in early neonatal life. Pediatr Res (1999) 0.81
Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure. Eur J Clin Microbiol Infect Dis (2013) 0.80
Diversity of vanA-type vancomycin-resistant Enterococcus faecium isolated from broilers, poultry slaughterers and hospitalized humans in Greece. J Antimicrob Chemother (2012) 0.80
Helicobacter pylori-induced gastritis in experimentally infected conventional piglets. Vet Pathol (2001) 0.80
Serum leptin concentrations during the perinatal period. Am J Perinatol (2000) 0.78
Serum soluble E- and L-selectin in the very early neonatal period. Early Hum Dev (2000) 0.78
Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin. Methods Find Exp Clin Pharmacol (1982) 0.78
Breast cancer markers during normal pregnancy. Anticancer Res (2000) 0.77
Angiogenic factors in the perinatal period: diversity in biological functions reflected in their serum concentrations soon after birth. Ann N Y Acad Sci (2000) 0.76
Basic fibroblast growth factor: serum levels in the female. Growth Factors (2000) 0.75
Failures of rifampicin and ciprofloxacin to eradicate a susceptible meningococcal isolate from a close contact of a fatal case. Infection (2001) 0.75
Trimebutine as a potential antimicrobial agent: a preliminary in vitro approach. Hippokratia (2012) 0.75
[Activity of lysozymes in the saliva of caries-susceptible and caries-resistant persons]. ZWR (1985) 0.75
[Bacteriology of dentoalveolar abscesses]. Rev Odontostomatol (Paris) (1984) 0.75
RAPD-fingerprinting of Serratia marcescens after formaldehyde inactivation of DNase activity. Lett Appl Microbiol (2000) 0.75
[Actinomycosis: apropos of a case of cervicofacial actinomycosis]. Rev Odontostomatol (Paris) (1984) 0.75
Peritonitis caused by Clostridium perfringens in a CAPD patient. Perit Dial Int (1999) 0.75
Hepatitis B vaccination in children with thalassemia in northern Greece. Biomed Pharmacother (1989) 0.75
The activity of cefetamet against enterobacterial isolates from community-acquired urinary tract infections. J Antimicrob Chemother (1996) 0.75
[Comparison in vivo and in vitro of the antibacterial action of the antiseptics hexetidine and povidone-iodine]. ZWR (1983) 0.75
[Vaccination against hepatitis B of children with of homozygous beta-thalassemia]. Presse Med (1988) 0.75
Adhesion molecules in early neonatal life. Biol Neonate (2000) 0.75
[Frequency of isolation of Actinobacillus actinomycetemcomitans and Capnocytophaga sp. in periodontitis in adults]. Rev Odontostomatol (Paris) (1986) 0.75
[Oral isolation of Neisseria gonorrhoeae in the presence of gonococcal urethritis]. Rev Odontostomatol (Paris) (1990) 0.75
[In vitro testing of the doxycycline sensitivity of anaerobic bacteria isolated from dental abscesses]. Stomatologia (Athenai) (1985) 0.75
Mucin-like carcinoma-associated antigen (MCA) during normal pregnancy. Eur J Obstet Gynecol Reprod Biol (2001) 0.75